UCL Therapeutic Innovations Networks (TINs)
Hosted by the UCL Translational Research Office (TRO), the Therapeutic Innovation Networks (TINs) follow a multidisciplinary approach, bringing together researchers and industry experts involved with a therapeutic modality, to tackle common obstacles and mobilise around strategic opportunities to accelerate translation.
The recognised UCL Therapeutic Innovation Networks (TINs) are: Biologics, Cell & Gene Therapies, Devices & Diagnostics, Regenerative Medicines, Repurposing and Small Molecules. Explore the TINs below to see how we can help with getting your therapeutic intervention to the clinic and learn about the success stories to come out of such collaborative work.
Share knowledge with researchers using monoclonal antibodies and therapeutic proteins to treat disease.
From CAR T to genetic engineering, this UCL community is world-leading in the translation of cell and gene therapies.
The Institute of Healthcare Engineering support the D&D TIN to transform patient care with digital technologies.
Now existing as a separate TIN, this network includes UCL's groundbreaking Tissue Engineering work.
Understand the translational pathway for drug repurposing: discovering new therapeutic uses for existing medicines.
Offering early drug discovery support with target identification, high throughput screening and medicinal chemistry.
Connect with researchers from across UCL and partner BRC's to accelerate translation around a therapeutic modality.